Insider Trading disclosures for Larimar Therapeutics Inc

The latest disclosure was made by Gopi Shankar in Larimar Therapeutics Inc where a trade of 23,306 Common Stock done was reported to US exchanges on Jan. 22, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Gopi Shankar	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	23,306	50,806	-		0	Common Stock
Gopi Shankar	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	139,838	139,838	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	546,000	546,000	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	91,000	387,208	-		0	Common Stock
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	34,185	178,181	-		0	Common Stock
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Jan 2025	205,111	205,111	-		-	Stock Option (Right to Buy)
Frank E. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
Jeffrey W. Sherman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
Jonathan S. Leff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
Flynn E James	Director, Ten Percent Owner, * Director by Deputization	Grant, award, or other acquisition of securities at price $ 0.00 per share.	29 May 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
Thomas Edward Hamilton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2024	19,000	19,000	-		-	Stock Option (Right to Buy)
James Flynn E	Director, Ten Percent Owner, * Director by Deputization	Purchase of securities on an exchange or from another person at price $ 8.74 per share.	16 Feb 2024	1,430,206	6,151,406	-	8.7	12,500,000	Common Stock
E Flynn James	Director, Ten Percent Owner, * Director by Deputization	Purchase of securities on an exchange or from another person at price $ 8.74 per share.	16 Feb 2024	1,430,205	4,207,982	-	8.7	12,499,992	Common Stock
Flynn James E	Director, Ten Percent Owner, * Director by Deputization	Purchase of securities on an exchange or from another person at price $ 8.74 per share.	16 Feb 2024	1,430,206	6,151,389	-	8.7	12,500,000	Common Stock
Thomas Edward Hamilton	Director	Purchase of securities on an exchange or from another person at price $ 8.74 per share.	16 Feb 2024	57,208	564,798	-	8.7	499,998	Common Stock
Frank E. Thomas	Director	Purchase of securities on an exchange or from another person at price $ 11.00 per share.	14 Feb 2024	2,000	2,000	-	11	22,000	Common Stock
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	396,750	396,750	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	66,125	332,954	-		0	Common Stock
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	187,500	187,500	-		-	Stock Option (Right to Buy)
Gopi Shankar	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	22,500	27,500	-		0	Common Stock
Celano Michael	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	31,250	143,996	-		0	Common Stock
Gopi Shankar	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2024	135,000	135,000	-		-	Stock Option (Right to Buy)
Shankar Gopi	Chief Development Officer	Purchase of securities on an exchange or from another person at price $ 3.73 per share.	07 Dec 2023	5,000	5,000	-	3.7	18,662	Common Stock
Carole Ben-Maimon	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 3.70 per share.	17 May 2023	5,000	266,829	-	3.7	18,525	Common Stock
Joseph Truitt	Director	Purchase of securities on an exchange or from another person at price $ 3.73 per share.	17 May 2023	2,750	2,750	-	3.7	10,258	Common Stock
Michael Celano	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 3.73 per share.	17 May 2023	5,000	112,746	-	3.7	18,632	Common Stock
Flynn James E	Director, Ten Percent Owner, * Director by Deputization	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 May 2023	8,300	8,300	-		-	Stock Option (Right to Buy)
Frank E. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 May 2023	8,300	8,300	-		-	Stock Option (Right to Buy)
Jonathan S. Leff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 May 2023	8,300	8,300	-		-	Stock Option (Right to Buy)
Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 May 2023	8,300	8,300	-		-	Stock Option (Right to Buy)
Thomas Edward Hamilton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 May 2023	8,300	8,300	-		-	Stock Option (Right to Buy)
Gopi Shankar	Chief Development Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Feb 2023	180,000	180,000	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2023	325,000	325,000	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2023	205,000	261,829	-		0	Common Stock
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2023	76,000	107,746	-		0	Common Stock
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Jan 2023	120,000	120,000	-		-	Stock Option (Right to Buy)
Michael Celano	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 3.15 per share.	16 Sep 2022	31,746	31,746	-	3.2	100,000	Common Stock
Carole Ben-Maimon	Director, President and CEO	Purchase of securities on an exchange or from another person at price $ 3.15 per share.	16 Sep 2022	31,746	56,829	-	3.2	100,000	Common Stock
Thomas Edward Hamilton	Director	Purchase of securities on an exchange or from another person at price $ 3.15 per share.	16 Sep 2022	317,460	507,590	-	3.2	999,999	Common Stock
Joseph Truitt	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	8,300	8,300	-		-	Stock Option (Right to Buy)
Frank E. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	8,300	8,300	-		-	Stock Option (Right to Buy)
Jonathan S. Leff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	8,300	8,300	-		-	Stock Option (Right to Buy)
Peter Barrett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	8,300	8,300	-		-	Stock Option (Right to Buy)
Thomas Edward Hamilton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	8,300	8,300	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	40,000	40,000	-		-	Stock Option (Right to Buy)
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	20,000	20,000	-		-	Stock Option (Right to Buy)
Carole Ben-Maimon	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2022	182,000	182,000	-		-	Stock Option (Right to Buy)
Michael Celano	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jan 2022	80,000	80,000	-		-	Stock Option (Right to Buy)
Thomas Edward Hamilton	Director	Purchase of securities on an exchange or from another person at price $ 8.75 per share.	30 Jun 2021	56,710	190,130	-	8.8	496,213	Common Stock

Showing 1 to 50 of 70 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

New 52W Low today

Insider Trading disclosures for Larimar Therapeutics Inc

The latest disclosure was made by Gopi Shankar in Larimar Therapeutics Inc where a trade of 23,306 Common Stock done was reported to US exchanges on Jan. 22, 2025.

Screeners based on Insider Trading and SAST parameters